Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susan DiAngelo is active.

Publication


Featured researches published by Susan DiAngelo.


Journal of General Virology | 1994

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies.

Neil D. Christensen; Reinhard Höpfl; Susan DiAngelo; Nancy M. Cladel; Susan D. Patrick; Patricia A. Welsh; Lynn R. Budgeon; Cynthia A. Reed; John W. Kreider

Baculovirus-expressed human papillomavirus type 11 (HPV-11) major capsid protein (L1) virus-like particles (VLPs) were produced in insect cells and purified on CsCl density gradients. The VLPs retained conformational neutralizing epitopes that were detected by a series of HPV-11-neutralizing monoclonal antibodies. Electron microscopy determined that the HPV-11 L1 VLPs were variable in size with a surface topography similar to that of infectious HPV-11. The VLPs were very antigenic, and induced high titres of neutralizing antibodies in rabbits and mice when used as an immunogen without commercial preparations of adjuvant. These VLP reagents may be effective vaccines for protection against HPV infections.


Virology | 1991

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

Neil D. Christensen; John W. Kreider; Nancy C. Kan; Susan DiAngelo

Polyclonal antisera were generated against bacterially derived fusion proteins of the open reading frames (ORFs) of the capsid proteins of cottontail rabbit papillomavirus (CRPV). The carboxy-terminal two-thirds of CRPV L1 and the carboxy-terminal half of CRPV L2 were cloned into a bacterial expression vector and induced proteins were used as antigen and immunogen. The polyclonal antisera were tested in a series of immunological assays, including ELISA, Western blot, and neutralization of CRPV. ELISA demonstrated that the polyclonal antisera raised against expressed L1 proteins reacted strongly to disrupted CRPV virion antigen and weakly both to intact CRPV virion and disrupted BPV-1 virion. Anti-CRPV L2 antisera reacted strongly only to intact and disrupted CRPV virion antigen. Viral capsid proteins of CRPV were detected in Western blots of HPV-11, BPV-1, and CRPV virus particles by these polyclonal antisera. The anti-L1 sera recognized the major capsid protein (60 kDa) and the anti-L2 sera identified a 76-kDa viral protein of CRPV. Only the antisera generated against expressed L2 neutralized CRPV. The neutralizing titer of the anti-L2 sera, however, was several orders of magnitude lower than the titer of a neutralizing polyclonal antiserum that was generated by immunizations with intact CRPV virions.


The Journal of Infectious Diseases | 2000

Surfactant Protein Genetic Marker Alleles Identify a Subgroup of Tuberculosis in a Mexican Population

Joanna Floros; Hung-Mo Lin; Andrea García; Miguel Angel Salazar; Xiaoxuan Guo; Susan DiAngelo; Martha Montaño; Junming Luo; Annie Pardo; Moisés Selman

Pulmonary surfactant and its components are essential for normal lung function and are involved in local host defense. Surfactant protein (SP)-A and SP-D bind to and modulate phagocytosis of Mycobacterium tuberculosis by macrophages. Frequency comparisons of SP marker alleles in tuberculosis patients and healthy control subjects (tuberculin-skin test positive or general population) were performed. Regression analyses of the tuberculosis and the tuberculin-skin test positive groups revealed, on the basis of odds ratios, tuberculosis susceptibility (DA11_C and GATA_3) and protective (AAGG_2) marker alleles. Similarly, between tuberculosis patients and general population control subjects, susceptibility 1A(3), 6A(4), and B1013_A and protective AAGG_1, and AAGG_7 marker alleles were observed. Moreover, interactions were seen between alleles 6A(2) and 1A(3) (P=.0064) and between 1A(3) and B1013_A (P=. 036). The findings indicate a possible involvement of SP alleles in tuberculosis pathogenesis.


Disease Markers | 1999

Novel, Non-Radioactive, Simple and Multiplex PCR-cRFLP Methods for Genotyping Human SP-A and SP-D Marker Alleles

Susan DiAngelo; Zhenwu Lin; Guirong Wang; Scott Phillips; Mika Rämet; Junming Luo; Joanna Floros

We have previously identified an allele of the human SP-A2 gene that occurs with greater frequency in an RDS population [12]. Because of the importance of SP-A in normal lung function and its newly emerging role in innate host defense and regu-lation of inflammatory processes, we wish to better characterize genotypes of both SP-A1 and SP-A2 genes. It has been determined that SP-D shares similar roles in immune response. Therefore, in this report we 1) describe a novel, non radioactive PCR based-cRFLP method for genotyping both SP-A and SP-D; 2) describe two previously unpublished biallelic polymorphisms within the SP-D gene; 3) present the partial sequence of one new SP-A1 allele (6A14) and describe other new SP-A1 and SP-A2 alleles; and 4) describe additional methodologies for SP-A genotype assessment. The ability to more accurately and efficiently genotype samples from individuals with various pulmonary diseases will facilitate population and family based association studies. Genetic poly-morphisms may be identified that partially explain individual disease susceptibility and/or treatment effectiveness.


Pediatrics International | 2001

Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome

Joanna Floros; Ruzong Fan; Susan DiAngelo; Xiaoxuan Guo; John Wert; Junming Luo

Abstract Background : The etiology of respiratory distress syndrome (RDS) is multifactorial and/or multigenic. Surfactant protein A (SP‐A) and/or SP‐B genetic variants have been identified as risk or protection factors for RDS.


Clinical Genetics | 2002

Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences

Joanna Floros; Ruzong Fan; A Matthews; Susan DiAngelo; Junming Luo; H Nielsen; M Dunn; I H Gewolb; Janna G. Koppe; L. van Sonderen; L Farri-Kostopoulos; M Tzaki; Mika Rämet; J Merrill

A key cause of respiratory distress syndrome (RDS) in the prematurely born infant is deficiency of pulmonary surfactant, a lipoprotein complex. Both low levels of surfactant protein A (SP‐A) and SP‐A alleles have been associated with RDS. Using the candidate gene approach, we performed family‐based linkage studies to discern linkage of SP‐A to RDS and identify SP‐A susceptibility or protective alleles. Moreover, we performed case–control studies of whites and blacks to detect association between RDS and SP‐A alleles. Transmission disequilibrium test (TDT) analysis revealed that the frequency of transmission (from parent to the offspring with RDS) of alleles 6A2 and 1A0 and of 1A0/6A2 haplotype in RDS was increased, whereas transmission of alleles 1A5 and 6A4 and of haplotype 1A5/6A4 was decreased. Extended TDT analysis further strengthened the observations made. The case–control studies showed that in whites or blacks with RDS the frequencies of specific genotypes, 1A0 and 6A2 or 1A0, were increased, respectively, but the frequency of specific 6A3 genotypes was increased in certain white subgroups and decreased in blacks. Regression analysis revealed gestational age (GA) and 6A3 genotypes are significant factors in blacks with RDS. In whites with RDS, GA and antenatal steroids are important factors. The data together indicate linkage between SP‐A and RDS; certain SP‐A alleles/haplotypes are susceptibility (1A0, 6A2, 1A0/6A2) or protective (1A5, 6A4, 1A5/6A4) factors for RDS. Some differences between blacks and whites with regard to SP‐A alleles may exist.


Disease Markers | 2006

Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia

Jelena Pavlovic; C. Papagaroufalis; Marietta Xanthou; Wenlei Liu; Ruzong Fan; Neal J. Thomas; Ioanna Apostolidou; E. Papathoma; E. Megaloyianni; Susan DiAngelo; Joanna Floros

BPD_28D (O2 dependency at 28 days of life) and BPD_36W (O2 dependency at 36 wks post-menstrual age) are diseases of prematurely born infants exposed to mechanical ventilation and/or oxygen supplementation. In order to determine whether genetic variants of surfactant proteins (SPs-A, B, C, and D) and SP-B-linked microsatellite markers are risk factors in BPD, we performed a family based association study using a Greek study group of 71 neonates (<30 wks gestational age) from 60 families with, 52 BPD_28D and 19 BPD_36W, affected infants. Genotyping was performed using newly designed pyrosequencing assays and previously published methods. Associations between genetic variants of SPs and BPD subgroups were determined using Transmission Disequilibrium Test (TDT) and Family Based Association Test (FBAT). Significant associations (p ≤ 0.01) were observed for alleles of SP-B and SP-B-linked microsatellite markers, and haplotypes of SP-A, SP-D, and SP-B. Specifically, allele B-18_C associated with susceptibility in BPD_36W. Microsatellite marker AAGG_6 associated with susceptibility in BPD_28D/36W group. Haplotype analysis revealed ten susceptibility and one protective haplotypes for SP-B and SP-B-linked microsatellite markers and two SP-A-SP-D protective haplotypes. The data indicate that SP loci are linked to BPD. Studies in different study groups and/or of larger sample size are warranted to confirm these observations and delineate genetic background of BPD subgroups.


Journal of Biological Chemistry | 2010

Humanized SFTPA1 and SFTPA2 Transgenic Mice Reveal Functional Divergence of SP-A1 and SP-A2: FORMATION OF TUBULAR MYELIN IN VIVO REQUIRES BOTH GENE PRODUCTS

Guirong Wang; Xiaoxuan Guo; Susan DiAngelo; Neal J. Thomas; Joanna Floros

Surfactant protein A (SP-A) plays a role in lung innate immunity and surfactant-related functions. Two functional genes, SP-A1 (SFTPA1) and SP-A2 (SFTPA2), are present in humans and primates (rodents have one gene). Single gene SP-A1 or SP-A2 proteins expressed in vitro are functional. To study their role in vivo, we generated humanized transgenic (hTG) C57BL/6 mice, SP-A1(6A4) and SP-A2(1A3). The SP-A cDNA in experimental constructs was driven by the 3.7-kb SP-C promoter. Positive hTG mice were bred with SP-A knock-out mice to generate F8 offspring for study. Epithelial alveolar type II cells were SP-A-positive, and Clara cells were negative by immunohistochemistry in hTG mice. The levels of SP-A in lungs of two hTG lines used were comparable with those in human lungs. Southern blot analysis indicated that two cDNA copies of either SP-A1(6A4) or SP-A2(1A3) were integrated as a concatemer into the genome of each of the two hTG lines. Electron microscopy analysis revealed that hTG mice with a single SP-A1(6A4) or SP-A2(1A3) gene product lacked tubular myelin (TM), but hTG mice carrying both had TM. Furthermore, TM was observed in human bronchoalveolar lavage fluid only if both SP-A1 and SP-A2 gene products were present and not in those containing primarily (>99.7%) either SP-A1 or SP-A2 gene products. In vivo rescue study confirmed that TM can only be restored after administering exogenous SP-A containing both SP-A1 and SP-A2 into the lungs of SP-A knock-out mice. These observations indicate that SP-A1 and SP-A2 diverged functionally at least in terms of TM formation.


Pediatric Research | 2009

Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus.

Neal J. Thomas; Susan DiAngelo; Joseph C. Hess; Ruzong Fan; Margaret W. Ball; Joseph M. Geskey; Douglas F. Willson; Joanna Floros

Severity of lung injury with respiratory syncytial virus (RSV) infection is variable and may be related to genetic variations. This preliminary report describes a prospective, family-based association study of children hospitalized secondary to RSV, aimed to determine whether intragenic and other haplotypes of surfactant proteins (SP)-A and SP-D are transmitted disproportionately from parents to offspring with RSV disease. Genomic DNA was genotyped for several SP-A and SP-D single nucleotide polymorphisms (SNPs). Transmission disequilibrium test analysis was used to determine transmission of variants and haplotypes from parents to affected offspring. Three hundred seventy-five individuals were studied, including 148 children with active RSV disease and one or both parents. The SP-A2 intragenic haplotype 1A2 was found to be protective (p = 0.013). The SP-D SNP DA160_A may possibly be an “at-risk” marker (p = 0.0058). Additional two- and three-marker haplotypes were associated with severe RSV disease, with two being protective (DA11_T/DA160_G and DA160_G/SP-A2 1A0/SP-A1 6A2). We conclude that there may be associations between SP-A and SP-D and RSV disease. Further study is required to determine whether these variants can be used to target a high-risk patient population in clinical trials aimed at reducing either the symptoms of acute infection or long-term pulmonary sequelae.


Acta Paediatrica | 2007

Haplotypes of the surfactant protein genes A and D as susceptibility factors for the development of respiratory distress syndrome.

Neal J. Thomas; Ruzong Fan; Susan DiAngelo; Joseph C. Hess; Joanna Floros

Aims: Polymorphisms of genes are transmitted together in haplotypes, which can be used in the study of the development of complex diseases such as respiratory distress syndrome (RDS). The surfactant proteins (SPs) play important roles in lung function, and genetic variants of these proteins have been linked with lung diseases, including RDS. To determine whether haplotypes of SP‐A and SP‐D are transmitted disproportionately from parents to offspring with RDS, we hypothesized that previously unstudied genetic haplotypes of these SP genes are associated with the development of RDS.

Collaboration


Dive into the Susan DiAngelo's collaboration.

Top Co-Authors

Avatar

Joanna Floros

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Patricia Silveyra

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Neal J. Thomas

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Guirong Wang

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Ruzong Fan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Xiaoxuan Guo

Penn State Milton S. Hershey Medical Center

View shared research outputs
Top Co-Authors

Avatar

Zhenwu Lin

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Junming Luo

Penn State Milton S. Hershey Medical Center

View shared research outputs
Top Co-Authors

Avatar

Zissis C. Chroneos

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Neil D. Christensen

Pennsylvania State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge